PRELUDD-PAYMENT-SERVICES
23.5.2023 20:01:33 CEST | Business Wire | Press release
Preludd Payment Services, a leading player in the instore payment industry, has strengthened its service offering and entered the Global market by acquiring Amadis.
Preludd Payment Services, has completed the acquisition of Amadis, a leading provider of EMV card-present payment acceptance solutions. With this acquisition, the company now offers solutions at all stages of the payment chain for payment solution providers, banks, acquirers, payment terminal distributors and SoftPOS.
The combination of Preludd and Amadis will create a future market leader in payment solutions.
Connecting payment terminals
Founded in 2016, Preludd offers a white-label cloud-based payment platform that securely connects POS terminals in France. As a payment platform, the company forwards payment data from POS terminals to banks and private acquirers. It also facilitates POS terminal fleets and associated SIM cards management and logistics.
A strategic acquisition
The acquisition of Amadis will enable the two entities to leverage their skills to serve a common ambition: the emergence of a leading player in Global payment solutions, with priority given to SoftPOS. Amadis is a payment card software development company providing EMV payment acceptance solutions on off the shelf systems (COTS) like smartphones and tablets and also PCI POS terminal hardware.
The company provides out-of-the-box compliance software that implements the global standards and requirements of all global payment networks. It has a world-class client portfolio and its solutions are deployed globally.
By leveraging Amadis' 18 years of experience, Preludd will be able to offer new and innovative solutions to make payments more accessible to everyone around the world.
With Amadis based in North America, Preludd in France and Middle-East, the group has a presence that allows it to be as close as possible to global issues.
Key figures
Preludd / Amadis
- Over 78 million connections are routed to banks each month
- +290,000 terminals connected
- + 7.5 billion euros in transit each month
- + 60 employees who are experts in electronic payments
- 100% coverage of the global EMV payment networks
- Technology present in +55 million banking terminals & SoftPOS
- Goal to reach more than 10 million euros in turnover by 2025
About Preludd Payment Services
Preludd is a cloud-based white label payment gateway. Our PCI-DSS hosted infrastructure securely connects retail outlets to international payment networks and routes millions of transactions per month to banks. More information on https://preludd.com/
About Amadis
Amadis provides card processing software and secure payment acceptance solutions, including SoftPOS, to payment terminal manufacturers and service providers. Amadis develops its software according to standards (such as EMVco, PCI and Nexo) for universal and agnostic compliance. More information on https://www.amadis.ca/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230523005009/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Gencom Acquires Rosewood London, Expanding Its Footprint With Its First Luxury Hotel Acquisition in Europe3.11.2026 19:05:00 CET | Press release
Located in one of the world’s most prestigious hospitality corridors, the acquisition of the 308-key hotel represents a major milestone in the firm’s international growth. Gencom, a U.S.-based investment firm that owns and develops prized real estate around the world, announces the acquisition of Rosewood London, the landmark 308-key luxury hotel situated at 252 High Holborn in Central London. The acquisition strengthens Gencom’s global hospitality investment platform and expands its presence in Europe through its first luxury hotel asset in London. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103137897/en/ Gencom, a U.S.-based investment firm that owns and develops prized real estate around the world, announces the acquisition of Rosewood London in Central London London is one of the world’s most supply-constrained hospitality markets, supported by year-round demand from both leisure and business travelers. The acquisi
SGCA Honours Communication Excellence Across Asia, Europe and the Arab World3.11.2026 16:52:00 CET | Press release
His Highness Sheikh Dr Sultan bin Ahmed bin Sultan Al Qasimi, Deputy Ruler of Sharjah and Chairman of the Sharjah Media Council, honoured winners of the 13th Sharjah Government Communication Award (SGCA), organised by the Sharjah Government Media Bureau (SGMB). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103972039/en/ SGCA honours communication excellence across Asia, Europe and the Arab world (Photo: AETOSWire) Winners represented China, India, Thailand, Ukraine and the Arab world. Some 433 entries from 31 countries across four continents passed initial screening. The award covered 23 categories across five sectors, including six partner awards. His Excellency Tariq Saeed Allay, Director General of SGMB, highlighted the award’s growth under the vision of His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, noting that it had attracted more than 9,500 entries over five year
BioLife to Showcase Oral Peptide Delivery Technology During London Life Sciences Week3.11.2026 16:03:00 CET | Press release
Company to highlight granted patent portfolio, preclinical semaglutide data and potential applications across future peptide medicines at LSX Investival BioLife Products Limited today announced its participation in London Life Sciences Week, where it will highlight its patented oral peptide delivery technology and recent advances in its intellectual property portfolio. BioLife will present at the LSX Investival Showcase on Monday, November 16, 2026, from 3:15 to 3:30 p.m. GMT, at Old Billingsgate, London. The presentation will be led by Former US Ambassador James P. Cain, Strategic Advisor to the Chairman & Founder, alongside Ludivine Delattre, Business and Corporate Relations, and will highlight the scientific journey behind the technology and its potential applications. BioLife is focused on developing a novel approach to delivering peptide therapeutics orally. Built on over 35 years of pharmaceutical effervescence expertise and two decades of oral peptide research by founder and inv
Sceye and SoftBank Corp. Sign Agreement for Fleet of Stratospheric Platforms Targeting Nationwide Coverage in Japan3.11.2026 16:00:00 CET | Press release
Five-year agreement builds on Sceye’s successful stratospheric connectivity tests in Japan and advances full-scale deployment of HAPS as stratospheric infrastructure and a key pillar of SoftBank’s strategy for a Ubiquitous Network Sceye, a U.S. aerospace and material science company building High Altitude Platform Systems (HAPS) for stratospheric infrastructure, today announced a five-year Master Services Agreement (MSA) with SoftBank Corp. (TOKYO:9434, “SoftBank”) to manufacture, launch, and operate a fleet of Sceye’s HAPS over Japan with the aim of achieving nationwide coverage. This agreement advances the companies’ partnership from flight demonstrations toward full-scale stratospheric infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103391128/en/ Sceye and SoftBank Corp. Sign Agreement for Fleet of Stratospheric Platforms Targeting Nationwide Coverage in Japan Sceye’s HAPS will form a key pillar of SoftB
Organigram to Acquire Aurora andEstablish a Global Cannabis Leader3.11.2026 15:16:00 CET | Press release
Organigram to acquire Aurora for C$7.80 per Aurora Common Share; Aurora shareholders will have the option to receive such Consideration in cash, Organigram shares or a combination of both, subject to proration. Transaction provides Aurora shareholders with certainty of value, meaningful immediate liquidity and participation in the combined entity Offer represents a 93% premium to Aurora’s Unaffected Share Price on August 10, 20261 and a 21% premium to the implied value of the unsolicited Curaleaf Hostile Bid as of November 2, 20262, unanimously rejected by Aurora’s Board of Directors Organigram shareholders to participate alongside Aurora shareholders in a company with greater scale, enhanced supply chain certainty, global footprint and diversification The combined company will own and operate five EU-GMP certified production and distribution facilities and bring world-class innovation to existing and new markets to meet international demand and support global market share expansion Th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom